The aim of this study was to evaluate the correlation between changes in the concentration of serum @entity1760 and serum immunoglobulin concentrations in @entity6 . In this study were included 110 @entity1 with @entity6 (64 @entity1 and 46 @entity1 ) with ages ranging from 19 to 54 years (mean age 41.6+/-6.8 years). The mean duration of the disease was 8.7+/-7.5 years. Thirty-six healthy subjects served as a control group. The serum @entity1760 concentrations were evaluated by VITROS 750 XRC, Johnson _ Johnson kit, (Ortho Clinical Diagnostics). Total serum IgA, IgG and IgM were determined by laser nephelometry (MININEPH The Binding Site kit). Values are means (x) + standard deviations (SD). Serum @entity1760 concentrations confirmed the @entity1760 deficit in @entity1 with @entity6 (1.8+/-0.11 mg/dL, range 1.73-2.47 mg/dL vs 2.2+/-0.2 mg/dL, range 1.6-2.4 mg/dL). In @entity1 with @entity6 , IgA levels are mildly elevated (4.03+/-0.51 g/L vs 3.43+/-0.48 g/L; p<0.05), while IgG levels are decreased (7.38+/-0.76 g/L vs 9.92+/-1.32 g/L; p<0.001) and IgM levels are almost constantly normal (1.18+/-0.16 g/L vs 1.22+/-0.15 g/L; p>0.05). Therefore, @entity1760 deficit has profound immunosuppressive capabilities in @entity1 with @entity6 by significantly reducing the number of IgG synthesizing cells and serum IgG concentrations.

The effect of @entity1760 deficit on serum immunoglobulin concentrations in XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'men'] @entity6 :: ('MESH:D003920', 'Disease') :: ['type 1 diabetes mellitus'] @entity1760 :: ('MESH:D008274', 'Chemical') :: ['magnesium']
@entity6 :: (MESH:D003920,Disease) :: ['type 1 diabetes mellitus']
